Entera Bio
ENTX
15 hedge funds and large institutions have $7.11M invested in Entera Bio in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
192% more capital invested
Capital invested by funds: $2.44M → $7.11M (+$4.68M)
50% more funds holding
Funds holding: 10 → 15 (+5)
2.1% less ownership
Funds ownership: 14.1% → 12.01% (-2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$165K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$57K |
| 3 |
VF
Virtu Financial
New York
|
+$24.3K |
| 4 |
Renaissance Technologies
New York
|
+$19.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$13.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$41.7K |
| 2 |
Morgan Stanley
New York
|
-$600 |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$324 |
ENTX Hedge Fund Activity: Q1 2024 in Review
15 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q1 2024, worth a combined $7.11M — up 192% from $2.44M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ENTX positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $165K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $41.7K sold.
- 15 institutional investors held Entera Bio (ENTX) as of Q1 2024, up from 10 in Q4 2023.
- Funds reported $7.11M of Entera Bio stock for Q1 2024, up 192% quarter-over-quarter.
- 7 funds opened new Entera Bio positions in Q1 2024 and 2 closed out, a net change of +5 holders.
- The largest Entera Bio buyer in Q1 2024 was UBS Group, an estimated $165K added.
- The largest Entera Bio seller in Q1 2024 was Two Sigma Securities, an estimated $41.7K sold.
Based on aggregated 13F filings for Q1 2024.